John H. Stroger Jr., Hospital of Cook County, Chicago, Illinois, United States of America.
PLoS One. 2022 Sep 2;17(9):e0273724. doi: 10.1371/journal.pone.0273724. eCollection 2022.
The commonly held association of hyperthyroidism with sinus tachycardia and widened pulse pressure (PP) has not been reassessed in decades despite patients with hyperthyroidism in current practice not always present with these signs. The study objective was to assess prevalence and variability of sinus tachycardia and widened PP in present day among individuals with different degrees of hyperthyroidism.
Data was collected retrospectively from 248 adult patients in an outpatient setting with biochemical evidence of hyperthyroidism, recorded heart rate (HR) and blood pressure (BP) who were not treated with medications that can influence these parameters.
Mean age was 42.0 ± 14.2 years with 66.9% being female. Median free thyroxine (fT4) level was 3.49 (IQR 2.42-4.58) ng/dL and thyroid stimulating hormone (TSH) 0.02 (IQR 0.01-0.03) mIU/L. Tachycardia, defined as HR >100 bpm, was present in 28.2%. In the lowest and highest fT4 quartiles, tachycardia was present in 16.4% and 38.7% respectively. Using logistic regression, tachycardia was associated with higher fT4 and diastolic BP. More lenient outcome of tachycardia with HR >90 bpm was seen in 47.2%. Widened PP, defined as >50 mmHg, was observed in 64.1% of patients and correlated with higher fT4 and BP.
Tachycardia is not a common feature of hyperthyroidism today. The relatively infrequent finding of tachycardia in this study compared to older studies may reflect differences in the way medicine is practiced today. The increased ordering of thyroid function tests most likely unmasked cases of mild or asymptomatic thyrotoxicosis. A widened PP was a more prevalent clinical finding in this study.
尽管当前实践中并非所有甲状腺功能亢进症患者都存在这些体征,但几十年来,人们一直认为甲状腺功能亢进症与窦性心动过速和脉压增宽(PP)有关,而这种关联并未得到重新评估。本研究的目的是评估目前不同程度甲状腺功能亢进症患者中窦性心动过速和脉压增宽的患病率和变异性。
从 248 名在门诊接受过甲状腺功能亢进症生化检查的成年患者中回顾性收集数据,记录心率(HR)和血压(BP),这些患者未接受可能影响这些参数的药物治疗。
平均年龄为 42.0±14.2 岁,女性占 66.9%。游离甲状腺素(fT4)中位数为 3.49(IQR 2.42-4.58)ng/dL,促甲状腺激素(TSH)为 0.02(IQR 0.01-0.03)mIU/L。心率>100 bpm 定义为心动过速,发生率为 28.2%。在 fT4 最低和最高四分位数中,心动过速的发生率分别为 16.4%和 38.7%。使用逻辑回归,心动过速与较高的 fT4 和舒张压相关。更宽松的心动过速标准(HR>90 bpm)的发生率为 47.2%。脉压增宽(定义为>50mmHg)发生率为 64.1%,与 fT4 和血压升高相关。
心动过速不是当今甲状腺功能亢进症的常见特征。与之前的研究相比,本研究中心动过速的相对少见发现可能反映了当今医学实践方式的差异。甲状腺功能检查的大量开单可能揭示了轻度或无症状甲状腺毒症病例。在本研究中,脉压增宽是更常见的临床发现。